NDC 68788-8711-06 - Donepezil Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8711
- Requested NDC
- 68788-8711-06
- Package NDCs from labels
- 68788-8711-3, 68788-8711-6, 68788-8711-9, 68788-8711-06
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-04-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Donepezil Hydrochloride - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-04-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8711-3 | Donepezil Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 68788-8711-6 | Donepezil Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 68788-8711-9 | Donepezil Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8711 | DONEPEZIL HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS INC.] | 2 | Current NDC, 3 package rows | 20250406_ee54a472-6783-41df-b8bb-9c3e4c996907.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8711-3 | EA - Each | 68788-8711 | 76192a7a-0ac4-4606-bf51-43ec25a7de78 | 1 | 2024-09-09 |
| 68788-8711-6 | EA - Each | 68788-8711 | ee2eedc6-05fb-4fa8-b244-2e5702641b8f | 1 | 2024-09-09 |
| 68788-8711-9 | EA - Each | 68788-8711 | d6f89586-785a-4d91-8846-0f396566a0b9 | 1 | 2024-09-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Donepezil | DONEPEZIL HYDROCHLORIDE | REMEDYREPACK INC. | 37fc6638-4a63-4582-a64c-3525f8ed7ef2 | 2026-09-09 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | REMEDYREPACK INC. | de96349a-5fee-4de9-921c-e453d44b3203 | 2026-09-09 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | A-S Medication Solutions | 0516d548-db9b-410a-aec9-79aedbc3f6e9 | 2026-08-18 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Golden State Medical Supply, Inc. | a085ed33-c262-44ab-e053-2a95a90a5557 | 2026-05-27 | Warnings, Adverse reactions | 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Upsher-Smith Laboratories, LLC | 12a755c5-1ad9-43d1-832a-eb2ff17bd693 | 2026-05-08 | Warnings, Adverse reactions | 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Cardinal Health 107, LLC | c942a4c9-dbe5-4131-bb6c-aa2d31b387e7 | 2026-04-24 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ee54a472-6783-41df-b8bb-9c3e4c996907 | 2026-04-08 | Warnings, Adverse reactions | ANDA078662 68788-8711-9 68788-8711-3 68788-8711-6 68788-8711 68788871106 997229 c9fdb857-2048-40fe-a3d1-4e89dda6cdf4 ee54a472-6783-41df-b8bb-9c3e4c996907 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 8138f616-83f3-4c47-84ef-1bce2db339f7 | 2026-04-08 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| donepezil hydrochloride | DONEPEZIL HYDROCHLORIDE | REMEDYREPACK INC. | 41c095b6-acd9-4627-a813-bbca7ecafee5 | 2026-03-30 | Warnings, Adverse reactions | 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Golden State Medical Supply, Inc. | 56abe961-ec94-4a77-b548-426f6255539e | 2026-03-09 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Namzaric | MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | Allergan, Inc. | 90fedc32-19e5-480c-afc6-f35a5cf4b9aa | 2026-03-06 | Warnings, Adverse reactions | 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Major Pharmaceuticals | c777ddc9-0b61-4d6f-95d6-818ba1861d62 | 2026-02-19 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | Torrent Pharmaceuticals Limited | 76bf638e-dbde-418e-8977-1caf009990bc | 2026-02-05 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil Hydrochloride | DONEPEZIL HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 6e9aacf9-abb6-4dec-9a8d-4eabf934d512 | 2026-01-30 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil | DONEPEZIL HYDROCHLORIDE | A-S Medication Solutions | 84d8ca68-26f3-4dd5-9dd4-6a7525a30db1 | 2026-01-20 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| donepezil hydrochloride | DONEPEZIL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | 1a8906ce-96dc-4bc8-81c1-5db67a187aac | 2025-12-19 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil | DONEPEZIL HYDROCHLORIDE | Quallent Pharmaceuticals Health LLC | c7e1f642-1bdc-4ed6-9b9e-c1af40b926cd | 2025-12-05 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil | DONEPEZIL HYDROCHLORIDE | American Health Packaging | 12ae85f0-023c-49ca-8c4a-0a6a7585290e | 2025-09-24 | Warnings, Adverse reactions | 997229 3O2T2PJ89D |
| Donepezil hydrochloride | DONEPEZIL HYDROCHLORIDE | Edenbridge Pharmaceuticals LLC. | 11404dc3-1bde-4d4e-8386-006b67ee19dd | 2025-08-01 | Warnings, Adverse reactions | 3O2T2PJ89D |
| Memantine and Donepezil | MEMANTINE AND DONEPEZIL | Macleods Pharmaceuticals Limited | 3d9a23dc-8cbe-47c3-a048-70d86cb9dc14 | 2025-07-10 | Warnings, Adverse reactions | 3O2T2PJ89D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.